Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
XLV vs XOVR: how they differ
XLV and XOVR hold 1% of their weight in the same names, and XLV returned more over the year.
State Street(R) Health Care Select Sector SPDR(R) ETF and ERShares Private-Public Crossover ETF.
What they hold in common
By the books each fund has filed, XLV and XOVR hold 1% of their money in the same securities at the same weight.
| Holding | XLV | XOVR |
|---|---|---|
| ResMed Inc | 0.49% | 1.36% |
| Veeva Systems Inc | 0.47% | 3.17% |
| Only in XLV | Only in XOVR |
|---|---|
| Eli Lilly & Co 16.56% | Nvidia Corp 9.48% |
| Johnson & Johnson 10.67% | Astera Labs Inc 7.75% |
| AbbVie Inc 7.76% | Alphabet Inc 6.53% |
| UnitedHealth Group Inc 6.59% | Meta Platforms Inc 4.47% |
| Merck & Co Inc 5.54% | Applovin Corp 3.95% |
| Amgen Inc 3.41% | Natera Inc 3.70% |
| Thermo Fisher Scientific Inc 3.25% | Robinhood Markets Inc 3.56% |
| Abbott Laboratories 2.76% | Reddit Inc 2.78% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| XLV State Street(R) Health Care Select Sector SPDR(R) ETF | XOVR ERShares Private-Public Crossover ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | State Street | ERShares |
| What it is | Health care | Private-Public Crossover |
| Total return, 1 year | +20.4% | 0.0% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +2.9 pts | −17.5 pts |
| Expense ratio | 0.08% | 0.75% |
| Already in the S&P 500 | 100.0% | 43.4% |
| Holdings | 59 | 32 |
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
XOVR in plain words
XOVR is an index equity fund tracking the Private-Public Crossover. Over the year to Sep 11, 2026 it returned 0.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.75% a year. By its holdings filed for Jun 30, 2026, 43% of the fund by weight is stocks the S&P 500 also holds, across 32 positions, with the top ten at 63.1%. It sat 4.2% below its high of Oct 27, 2025 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, XLV or XOVR?
- In the year to Sep 12, 2026, with distributions reinvested, XLV returned +20.4% and XOVR returned 0.0%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, XLV or XOVR?
- XLV charges 0.08% a year and XOVR charges 0.75%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do XLV and XOVR overlap with the S&P 500?
- By their latest filed holdings, 100% of XLV and 43% of XOVR by weight is stocks the S&P 500 already holds. Between the two funds, 1% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, XLV against XOVR, data as of Sep 12, 2026. https://etfiq.com/compare/any/XLV-XOVR Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources